Evidence map›Paper›PMID 40183949›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2025

Leveraging machine learning with dynamic 18F-FDG PET/CT: integrating metabolic and flow features for lung cancer differential diagnosis.

Zhiheng Yao, Yubo Wang, Yaping Wu, Jinpeng Zhou, Na Dang, Meiyun Wang, Ying Liang, Tao Sun

Abstract read
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zhiheng Yao *Paul C. Lauterbur Research Center for Biomedical Imaging, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, People's Republic of China.
Yubo Wang *Department of Nuclear Medicine, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, People's Republic of China.
Yaping WuHenan Provincial People's Hospital and Zhengzhou People's Hospital, Zhengzhou University, Zhengzhou, People's Republic of China.
Jinpeng ZhouDepartment of Nuclear Medicine, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, People's Republic of China.
Na DangDepartment of Nuclear Medicine, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, People's Republic of China.
Meiyun WangHenan Provincial People's Hospital and Zhengzhou People's Hospital, Zhengzhou University, Zhengzhou, People's Republic of China.
Ying LiangDepartment of Nuclear Medicine, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, People's Republic of China. liangying@cicams-sz.org.cn.
Tao SunPaul C. Lauterbur Research Center for Biomedical Imaging, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, People's Republic of China. tao.sun@siat.ac.cn.

Funding

Key Laboratory for Magnetic Resonance and Multimodality Imaging of Guangdong Province 2023B1212060052Shenzhen Science and Technology Innovation Committee 20220531100209020
6 · The paper itself

Abstract

backgroundDynamic 18F-fluorodeoxyglucose (18F-FDG) PET/CT imaging has been shown to provide additional information for diagnosing lung cancer. The aim of this study was to investigate whether metabolic and flow features directly extracted from time activity curves (TACs) help differentiate between benign and malignant conditions of lung lesions.

methodsTACs at the primary lesion were extracted from each dynamic 18F-FDG PET/CT scan. The TAC signal was then decomposed into metabolism and blood flow components through kinetic modeling. Dynamic features including area under the curve (AUC), time-to-peak, and slopes were then extracted from each component. The extracted features from 187 patients (mean age, 60.41 ± 11.01 years; 117 males) were used to train a classification model based on bagging, a machine-learning method built with decision trees. The performance of the trained model on differentiating benign and malignant was tested using receiver operating characteristic analysis with cross-validation. External testing was then performed for an independent dataset that consisted of 42 dynamic scans. For the results, SHapley Additive exPlanations (SHAP) were used to assess the relative importance of the contributed features for individuals. Waterfall charts were also plotted, together with assessment of Cohen's effect size to demonstrate the superiority of the proposed model over SUVmax and the net FDG influx rate K

resultsThe combination of the multiple dynamic features was able to separate benign and malignant lesions. For cross-validation, the trained model had an AUC of 0.89, sensitivity of 0.80, and specificity of 0.88, which was significantly higher than that of either SUVmax (AUC = 0.79, DeLong p < 0.001) or K

conclusionAn explainable machine learning model that combines dynamic FDG metabolic and flow features can predict benign or malignant lung cancer patients more accurately than conventional parameters such as SUVmax or net influx rate K

Indexed as

Fluorodeoxyglucose F18Lung NeoplasmsMachine LearningPositron Emission Tomography Computed TomographyAgedDiagnosis, DifferentialFemaleHumansMaleMiddle AgedFluorodeoxyglucose F18Dynamic 18F-FDG PET/CTLung cancer diagnosisMachine learningSHAP interpretabilityTime activity curves

Identifiers

PMID40183949
PMCPMC12316803

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.